PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.95 CHF 4.1% Market Closed
Market Cap: 921.9m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

PolyPeptide Group AG
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PolyPeptide Group AG
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
PolyPeptide Group AG
SIX:PPGN
Net Income (Common)
-€51.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Net Income (Common)
CHf113.6m
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
16%
Siegfried Holding AG
SIX:SFZN
Net Income (Common)
CHf128.2m
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Net Income (Common)
CHf573m
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
12%
Tecan Group AG
SIX:TECN
Net Income (Common)
CHf101.3m
CAGR 3-Years
-12%
CAGR 5-Years
9%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Net Income (Common)
CHf26.3m
CAGR 3-Years
80%
CAGR 5-Years
35%
CAGR 10-Years
N/A
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
921.9m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
24.99 CHF
Overvaluation 11%
Intrinsic Value
Price

See Also

What is PolyPeptide Group AG's Net Income (Common)?
Net Income (Common)
-51.4m EUR

Based on the financial report for Dec 31, 2023, PolyPeptide Group AG's Net Income (Common) amounts to -51.4m EUR.

Back to Top